
Gregory Daniels
Professor of Medicine · University of California (San Diego) Medical Center
Credentials: · · · ·
History
- 2002–2004
Medical Oncology
- 1999–2002
Internal Medicine

Research
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2019 · 2,973 citations
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Journal of Clinical Oncology · 2015 · 2,112 citations
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Molecular Cancer Therapeutics · 2017 · 1,827 citations

16 papers
- RG
12 papers

11 papers
- HK
10 papers

10 papers
- BP
9 papers

9 papers

8 papers
Clinical trials
- 2020–2023
Principal investigator · Terminated · Phase 1
Gregory Daniels
- 2019–2024
High Dose IL-2 in Combination With Anti-PD-1
Principal investigator · Terminated · Phase 2
Gregory Daniels
- 2012–2018
Principal investigator · Unknown · Phase 1
OncBioMune Pharmaceuticals
- 2009–2013
Principal investigator · Completed · Phase 1
University of California, San Diego


